Sorry, the english version of this page is currently not available.

Chefsache

Prof. Dr. Bernhard Hirt, Ärztlicher Direktor des Instituts für Klinische Anatomie und Zellanalytik, und Prof. Dr. Arnulf Stenzl, Ärztlicher Direktor der Universitätsklinik für Urologie und Direktor des Interuniversitären Zentrums für Medizinische Technologien Stuttgart – Tübingen (IZST) moderieren die Diskussion mit Ärztlichen Direktoren und Oberärzten, während Eingriffe am anatomischen Präparat live endoskopisch und offen-chirurgisch dargestellt werden. Die Workshops finden regelmäßig zu jeweils anderen Schwerpunktthemen statt.

In der Broschüre erhalten Sie nützliche Informationen rund um den Workshop "Einschnitte - Einblicke".

/en/node/245
02/27/2019

New instruments for old bones

The workshop series "Incisions and insights - medtech engineers and medical practitioners in dialogue on anatomy" continued in February 2019, focusing on "extremities and the musculoskeletal system". Live-streamed surgery and practical exercises in the operating theatre at the Institute of Clinical ...
10/30/2018

High-tech information systems take the place of a note stuck on a lamp

Success story in the “Incisions and insights” workshop series:
Reutlingen University and RZ Medizintechnik develop innovative tablet solution for the operating theatre

07/10/2018

Ideas brought to life in Anatomy

Incisions and insights workshop series – “Heart, lungs, thorax”

 

 

Bei Fragen wenden Sie sich bitte an Herrn Dr. Klaus Eichenberg

Klaus Eichenberg, Dr. rer. nat.

Managing Director
+49-711-870354-22
Managing Director
Klaus Eichenberg, Dr. rer. nat.

"After my studies in biology with a focus on molecular and cellular biology at the University of Freiburg followed by a doctorate in physiology, I trained myself to become an investment analysts. In addition to research activities at the Technion in Israel, I publish some scientific articles for example in "Science". As a business consultant I was in the life sciences team at Ernst & Young/ Capgemini, before I took care of biotechnology and pharmaceutical values as a financial analyst at the Hypo-Vereinsbank. After some time as a freelance consultant for the Steinbeis network, I switched to BioRegio STERN in February 2004. As managing director of BioRegio STERN Management GmbH I represent the scientific and economic interests of the BioRegion. I commit myself to the sustainable growth of the biotech-location STERN and the positioning in top international ranks. In addition, for six years I was spokesman for the BioRegions of Germany."